Andrew John Grose, MD | |
21145 Bank Mill Rd, Saratoga, CA 95070-5706 | |
(408) 823-2476 | |
Not Available |
Full Name | Andrew John Grose |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 21145 Bank Mill Rd, Saratoga, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649380668 | NPI | - | NPPES |
00G179770 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | G17977 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Andrew John Grose, MD 21145 Bank Mill Rd, Saratoga, CA 95070-5706 Ph: (408) 823-2476 | Andrew John Grose, MD 21145 Bank Mill Rd, Saratoga, CA 95070-5706 Ph: (408) 823-2476 |
News Archive
Tina's Wish, the only nonprofit organization dedicated exclusively to funding research for the early detection of ovarian cancer, honored President Bill Clinton with the inaugural Tina's Wish Global Women's Health Award at a reception at the Waldorf Astoria New York on April 14th.
For women with metastatic breast cancer who had elevated amounts of circulating tumor cells (CTCs) in their blood after a first line of chemotherapy, switching immediately to a different chemotherapy did not improve overall survival or time to progression, according to the results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Stem cells. Few research discoveries hold as much promise of single-handedly expanding medical treatment options as they do. Miraculously able to act as transformers-;either re-creating or morphing into a variety of cell types found within the organisms they originate from-;stem cells offer humanity hope for new, more effective therapies against a number of chronic and terminal diseases. And finding them is surprisingly easy.
New research led by Naresh Trehan of Medanta-The Medicity in India found the COVISHIELD (ChAdOx1 nCoV-19 Corona Virus Vaccine) vaccine produced an immune response from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) two weeks after vaccination with limited side effects.
› Verified 4 days ago